Corey Cavanaugh

Cleveland Clinic — United States

Medicine · Health Sciences

5h-index296citations21works0.82yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Renal Diseases and Glomerulopathies(9), Autoimmune Bullous Skin Diseases(3), Chronic Kidney Disease and Diabetes(2), Coagulation, Bradykinin, Polyphosphates, and Angioedema(2), Renal and Vascular Pathologies(2)

Publications21 total

Urine Microscopy
Kidney360·2025Open Access
Prophylactic Anticoagulant Use in Primary Membranous Nephropathy
Journal of the American Society of Nephrology·2025
Primary Hyperaldosteronism Presenting Clinically as Classic Pheochromocytoma
Journal of the American Society of Nephrology·2025
Clinical uptake of an antigen-based approach to membranous nephropathy: a survey of general nephrologists and glomerular disease experts
Journal of Nephrology·2025Open Access
IgA nephropathy: Update on pathogenesis and treatment
Cleveland Clinic Journal of Medicine·2025· 4 citedOpen Access
Thrombotic Microangiopathy and Membranous Nephropathy: A Complicated Paraneoplastic Disorder
Journal of the American Society of Nephrology·2024· 2 cited
Failure Is a Learning Experience: A Case of Lupus Vasculopathy without Clinical Response to Rituximab
Journal of the American Society of Nephrology·2024· 1 cited
Thrombotic Microangiopathy in Scleroderma: Is It Always a Crisis?
Journal of the American Society of Nephrology·2024
Serum protein electrophoresis patterns and misleading laboratory values in IgG4-RD: what the nephrologist should know
Journal of Nephrology·2024Open Access
A 35-Year History of Lupus Nephritis Without Renal Fibrosis or Scarring: How Is This Possible? Exostosin 2
Journal of the American Society of Nephrology·2023
Ofatumumab: A Therapeutic Option for Secondary Membranous Nephropathy in Adults
Journal of the American Society of Nephrology·2023· 1 cited
Compressed and Concomitant Cyclophosphamide with Prednisone for Membranous Nephropathy: Low Doses for Very-High-Risk Patients
Journal of the American Society of Nephrology·2023· 1 cited
Treatment of membranous nephropathy: Perspectives on current and future therapies
Frontiers in Nephrology·2023· 7 citedOpen Access
Bamboozled: Concomitant Lupus Nephritis and Systemic Thrombotic Microangiopathy
Journal of the American Society of Nephrology·2022
A Case of Fibrillary Glomerulonephritis Presenting With Asthma Responsive to Corticosteroids
Journal of the American Society of Nephrology·2022
Urine Sediment Exam Provides More Diagnostic Information in AKI than Novel Urinary Biomarkers: PRO
Kidney360·2021· 3 citedOpen Access
The Evolving Role of Novel Biomarkers in Glomerular Disease: A Review
American Journal of Kidney Diseases·2020· 21 citedOpen Access
Podocyte histone deacetylase activity regulates murine and human glomerular diseases
Journal of Clinical Investigation·2019· 60 citedOpen Access
Telavancin-associated acute kidney injury
Clinical Nephrology·2019· 11 cited
Urine Sediment Examination in the Diagnosis and Management of Kidney Disease: Core Curriculum 2019
American Journal of Kidney Diseases·2018· 185 cited
page 1 of 2Next →

Frequent Co-authors

Mark A. Perazella(3), Leal Herlitz(3), Eibhlin Goggins(3), Monarch Shah(2), Andrew DeLaat(2), Seshma Ramsawak(2), Ali Mehdi(2), Kazunori Inoue(1), Geliang Gan(1), Maria Ciarleglio(1), Yan Zhang(1), Xuefei Tian(1), Christopher E. Pedigo(1), Janet Tate(1), Ying Wang(1), Elizabeth Cross(1), Marwin Groener(1), Nathan Chai(1), Zhen Wang(1), Amy C. Justice(1)